CompletedPhase 2NCT04017936

Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis

Studying Sarcoidosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Virginia Commonwealth University
Principal Investigator
Jordana Kron, MD
Virginia Commonwealth University
Intervention
Anakinra(drug)
Enrollment
17 target
Eligibility
21 years · All sexes
Timeline
2020 – 2024

Study locations (2)

Collaborators

American Heart Association · National Center for Advancing Translational Sciences (NCATS)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04017936 on ClinicalTrials.gov

Other trials for Sarcoidosis

Additional recruiting or active studies for the same condition.

See all trials for Sarcoidosis →

← Back to all trials